USV India
USV India is a leading healthcare company specializing in OAD and Cardiology markets, with a strong presence in India and international markets including Asia, Africa, CIS countries, and Europe.
Services
USV India offers a comprehensive range of healthcare products and services, including Active Pharmaceutical Ingredients (APIs), Peptides, Biosimilars, Injectables, Ophthalmics, and Solid Orals. The company holds a significant presence in both the domestic and international pharmaceutical markets. USV is recognized for its substantial contributions to the OAD and Cardiology sectors, maintaining leading positions in these markets for over two decades.
Market Leadership
USV India is a market leader in the Oral Antidiabetic (OAD) market and Cardiology sector, both by prescription and value. The company has maintained its leading positions in these markets for the past 20 years. It competes successfully with reputed multinational companies in the finished dosage markets across India, Asia, Africa, and CIS countries. The company's Peg GCSF is approved for the Australian market under the brand name Filpegla.
Products
Among USV India's notable products are Vildagliptin & Pioglitazone tablets, which obtained marketing authorization for the domestic market through in-house development, and UDAPA S, a fixed-dose combination of Dapagliflozin 10 mg and Sitagliptin 100 mg. The company started commercial supplies for its leading brand, Glycomet GP, from its state-of-the-art Vadodara plant in July 2022. USV also introduced Filpegla (Peg GCSF) in the Australian market.
International Expansion
USV India has expanded internationally, focusing on key markets such as the US and Europe for export revenues. The company made a significant move into the German market by acquiring Juta Pharma GmbH, a company holding more than 50 marketing authorizations for generic drugs. Germany's pharmaceuticals market is the largest in Europe and the fourth largest globally. This strategic acquisition enhances USV's footprint in these critical markets.
History
USV India is a 62-year-old healthcare company that began as a joint venture with USV & P Inc., a subsidiary of Revlon. Throughout its history, USV has been a pioneering force in the pharmaceutical industry, overcoming various challenges such as remediation hurdles for its Daman manufacturing facility. The company’s commitment to innovation and quality has secured its position as a leader in the pharmaceutical sector.